Organised by SHC

Singapore
MASLD Symposium

For the Clinician, Researcher and
Pharmaceutical Executive

Sunday, 24 August 2025

8:30 am to 5:00 pm (SGT)

Singapore MASLD Symposium

Sunday, 24 August 2025

8:30 am to 5:00 pm (SGT)

REGISTRATION FOR The 1st Asian Hepatology Summit includes Singapore MASLD Symposium 2025.

The Singapore MASLD Symposium 2025 will feature an extensive line up of World Renowned Experts from Academia AND Industry in the fast developing field of MASLD. They will share and provide a comprehensive update on their research works.

REGISTER HERE for 1st Asian Hepatology Summit which includes the Singapore MASLD Symposium at no extra charge

To access SHC e-Resources REGISTER HERE or LOG IN (if you have previously registered for SHC)

Meet Our Experts

Singapore MASLD Symposium 2025 Scientific Programme

in Ballroom 2

August 2025

24

Advancing Care in MASLD Programme Time (SGT)
Welcome  Address 8.20 – 8.30
Theme 1: Integration
Chair: Dr. Mark Muthiah & Dr. Daniel Huang
Global format for care pathways in metabolic medicine –
how is the world moving towards integration
Prof. Arun Sanyal View Bio
8.30 – 8.50
A pathobiological view of common biological roots of
metabolic end organ damage
Prof. Quentin Antsee View Bio
8.50 – 9.10
Multi-organ outcomes in MASLD
Prof. Dan Yock Young View Bio
9.10 – 9.30
Case based discussions: extrahepatic involvement in MASLD
Dr. Nicholas Chew View Bio
9.40 – 10.10
Combined Q&A 10.10 – 10.30
Tea Break 10.30 – 10.50
Theme 2: Diagnostics
Chair: Prof. Atsushi Nakajima and Prof. Ming Hua Zheng
Unmet needs in diagnostics: a patient centered view
Prof. Chan Wah Kheong View Bio
10.50 – 11.10
From diagnostics to surrogate endpoints: current state of
the art
Prof. Quentin Anstee View Bio
11.10 – 11.30
Innovations in diagnostics
Prof. Arun Sanyal View Bio
11.30 – 11.50
Case based discussions: challenges in diagnostics
Prof. Atsushi Nakajima View Bio and Dr. Mark Muthiah View Bio
11.50 – 12.20
Combined Q&A 12.20 – 12.40
Gilead Sciences Lunch Symposium 12.40 – 14.00
a. Charting the path to HCV elimination in South East Asia –
overview of national plans, screening targets, integration into
primary care towards WHO 2030 goal
Dr. John Ward View Bio
12.45 – 13.05
b. From diagnosis to cure: scale up test and treat and practical
models to decentralise HCV care
Prof. Philippa Easterbrook View Bio
13.05 – 13.25
c. Closing the gaps: Advancing Singapore towards HCV elimination
Prof. Wong Chen Seong View Bio
13.25 – 13.45
d. Q&A
Theme 3: Treatment
Chair: Dr. Daniel Huang & Dr. Mark Muthiah
Top-down vs bottom up strategies in MASLD therapeutics?
Prof. Arun Sanyal View Bio
14.00 – 14.20
Dual and triple agonists, are they better than single agonists of the incretin pathway?
Prof. Elizabeth Powell View Bio
14.20 – 14.40
When and how of combination therapies
Prof. Zheng Ming Hua View Bio
14.40 – 15.00
Case based discussion: management challenges
Dr. Mark Muthiah View Bio Prof. Dan Yock Young View Bio
15.00- 15.30
Tea Break 15.30 – 15.50
Theme 4: Hot topics
Chair: Dr. Yew Kuo Chao & Prof. Chan Wah Kheong
Non hepatic cancer in MASLD
Prof. Asahiro Morishita View Bio
15.50 – 16.10
Implications of MASLD for women of childbearing years
Dr. Mark Muthiah View Bio
16.10 – 16.30
Neurocognitive decline in MASLD
Prof. Ajay Duseja View Bio
16.30 – 16.50
HCC and the core total in MASLD
Dr. Daniel Huang View Bio
16.50 – 17.10
Combined Q&A 17.10 – 17.30
Closing address 17.30 – 17.40

Who Should Attend?

Singapore MASLD Symposium 2025 is designed for Scientists (virologists, Immunologists), Clinician Scientists, pharmacists and Industry Experts, to exchange information on the latest research, discuss new developments in the management and treatment of MASLD

REGISTER HERE for 1st Asian Hepatology Summit which includes the Singapore MASLD Symposium at no extra charge

To access SHC e-Resources REGISTER HERE or LOG IN (if you have previously registered for SHC)

Organized by:

In conjunction with: